SS
Samantha Semenkow Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
34
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $35 |
42%
upside
| 1 | +8.6% |
0
%
| 3 Mar ‘26 yesterday |
|
|
|
Buy
Maintained
| $14 |
157%
upside
| 1 | +48% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Buy
Initiated
| $33 |
102%
upside
| 1 | +41% |
0
%
| 17 Feb ‘26 16 days ago |
|
|
|
Buy
Maintained
| $35 |
19%
upside
| 1 | +27% |
0
%
| 10 Feb ‘26 22 days ago |
|
|
|
Buy
Maintained
| $1,091 |
46%
upside
| 1 | +9.5% |
0
%
| 8 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $14.50 |
1%
upside
| 2 | +30% |
0
%
| 22 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $64 |
56%
upside
| 1 | +24% |
0
%
| 17 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $30 |
119%
upside
| 1 | +57% |
0
%
| 9 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $100 |
58%
upside
| 1 | +73% |
0
%
| 9 Dec ‘25 2 months ago |
|